The effects of swainsonine on the activity and expression of α-mannosidase in BRL-3A cells

Swainsonine (SW) is the principal toxic ingredient of locoweeds, which can cause intensive vacuolar degeneration because of α-mannosidase inhibition after animal ingestion. While SW can lead to obvious liver damage in vivo, the mechanism of hepatotoxic damage caused by SW is not clear. Therefore, BR...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Toxicon (Oxford) 2015-06, Vol.99, p.44-50
Hauptverfasser: Lu, Hao, Ma, Feng, Wang, Huan, Geng, Peng-shuai, Wang, Shan-shan, Wang, Jian-guo, Wu, Chen-chen, Zhao, Bao-yu
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 50
container_issue
container_start_page 44
container_title Toxicon (Oxford)
container_volume 99
creator Lu, Hao
Ma, Feng
Wang, Huan
Geng, Peng-shuai
Wang, Shan-shan
Wang, Jian-guo
Wu, Chen-chen
Zhao, Bao-yu
description Swainsonine (SW) is the principal toxic ingredient of locoweeds, which can cause intensive vacuolar degeneration because of α-mannosidase inhibition after animal ingestion. While SW can lead to obvious liver damage in vivo, the mechanism of hepatotoxic damage caused by SW is not clear. Therefore, BRL-3A cells were treated for 24, 48, and 72 h with SW at various concentrations (0, 700, 900, 1100 μg/mL). The α-mannosidase (AMAN) activity was determined in BRL-3A cells using an enzyme substrate technique. The expression of mRNA and proteins of GM II (MAN2A1) and LAM (MAN2B1) in BRL-3A cells was detected by qPCR and Western-blot. The results showed that SW could significantly reduce the activity of AMAN in a time-dose effect relationship. Compared with the control group, the activity of AMAN significantly decreased only in the group treated with 1100 μg/mL SW for 24 h (P 
doi_str_mv 10.1016/j.toxicon.2015.03.008
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1770348954</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0041010115000707</els_id><sourcerecordid>1732819980</sourcerecordid><originalsourceid>FETCH-LOGICAL-c431t-83791d708d1490f8b00835f7a45c05cb83cf009facabcde26643077623a4bb5c3</originalsourceid><addsrcrecordid>eNqNkcFOGzEQhq2qqITAI7TysZddxuv12j5VFLWAFKkSghMHy-sdq44SO11vKDwWL9JnqqOkvcJpDvPN_P_MT8hHBjUD1p0v6yk9BZdi3QATNfAaQL0jM6akrjgT8J7MAFpWQcGPyUnOSwDgSncfyHEjpJacyRl5uPuJFL1HN2WaPM2_bYg5xRCRpkin0rVuCo9heqY2DhSfNiPmHEqv0H9eqrWNMeUw2Iw0RPr1dlHxC-pwtcqn5MjbVcazQ52T--_f7i6vq8WPq5vLi0XlWs6mSnGp2SBBDazV4FVfDuHCS9sKB8L1ijsPoL11tncDNl3XcpCya7ht-144Pief93s3Y_q1xTyZdcg7BzZi2mbDpATeKi3aN6C8UUxrBQUVe9SNKecRvdmMYW3HZ8PA7CIwS3OIwOwiMMDNzvmcfDpIbPs1Dv-n_v28AF_2AJafPAYcTXYBo8MhjCUGM6TwisRfVZ2aDA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1732819980</pqid></control><display><type>article</type><title>The effects of swainsonine on the activity and expression of α-mannosidase in BRL-3A cells</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Lu, Hao ; Ma, Feng ; Wang, Huan ; Geng, Peng-shuai ; Wang, Shan-shan ; Wang, Jian-guo ; Wu, Chen-chen ; Zhao, Bao-yu</creator><creatorcontrib>Lu, Hao ; Ma, Feng ; Wang, Huan ; Geng, Peng-shuai ; Wang, Shan-shan ; Wang, Jian-guo ; Wu, Chen-chen ; Zhao, Bao-yu</creatorcontrib><description>Swainsonine (SW) is the principal toxic ingredient of locoweeds, which can cause intensive vacuolar degeneration because of α-mannosidase inhibition after animal ingestion. While SW can lead to obvious liver damage in vivo, the mechanism of hepatotoxic damage caused by SW is not clear. Therefore, BRL-3A cells were treated for 24, 48, and 72 h with SW at various concentrations (0, 700, 900, 1100 μg/mL). The α-mannosidase (AMAN) activity was determined in BRL-3A cells using an enzyme substrate technique. The expression of mRNA and proteins of GM II (MAN2A1) and LAM (MAN2B1) in BRL-3A cells was detected by qPCR and Western-blot. The results showed that SW could significantly reduce the activity of AMAN in a time-dose effect relationship. Compared with the control group, the activity of AMAN significantly decreased only in the group treated with 1100 μg/mL SW for 24 h (P &lt; 0.01), but the activity decreased significantly (P &lt; 0.05 or P &lt; 0.01) in all experimental groups treated for 48 or 72 h. SW also significantly reduced the expression of MAN2A1 and MAN2B1 mRNA and proteins in a time-dose effect relationship (P &lt; 0.05 or P &lt; 0.01), while the inhibition of SW was stronger for MAN2B1 than for MAN2A1. These results suggest that SW can significantly reduce the activity and expression of α-mannosidase thus causing SW-induced hepatotoxic damage. •The effect of swainsonine on the activity and expression of α-mannosidase in hepatic cells was observed for the first time.•Swainsonine caused the damage of liver tissues through inhibiting the activity and expression of α-mannosidase in hepatic cells.</description><identifier>ISSN: 0041-0101</identifier><identifier>EISSN: 1879-3150</identifier><identifier>DOI: 10.1016/j.toxicon.2015.03.008</identifier><identifier>PMID: 25797317</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>alpha-Mannosidase - antagonists &amp; inhibitors ; alpha-Mannosidase - genetics ; alpha-Mannosidase - metabolism ; Animals ; Biocompatibility ; Biomedical materials ; BRL-3A cells ; Cell Line ; Cell Survival - drug effects ; China ; Damage ; Enzyme Repression - drug effects ; Gene expression ; Golgi Apparatus - drug effects ; Golgi Apparatus - enzymology ; Hepatocytes - drug effects ; Hepatocytes - enzymology ; Hepatocytes - metabolism ; In vivo testing ; In vivo tests ; Inhibition ; Isoenzymes - antagonists &amp; inhibitors ; Isoenzymes - genetics ; Isoenzymes - metabolism ; Kinetics ; Locoweed ; Lysosomes - drug effects ; Lysosomes - enzymology ; MAN2A1 ; MAN2B1 ; Oxytropis - chemistry ; Proteins ; Rats ; RNA, Messenger - metabolism ; Swainsonine ; Swainsonine - toxicity ; Toxins, Biological - toxicity</subject><ispartof>Toxicon (Oxford), 2015-06, Vol.99, p.44-50</ispartof><rights>2015 Elsevier Ltd</rights><rights>Copyright © 2015 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c431t-83791d708d1490f8b00835f7a45c05cb83cf009facabcde26643077623a4bb5c3</citedby><cites>FETCH-LOGICAL-c431t-83791d708d1490f8b00835f7a45c05cb83cf009facabcde26643077623a4bb5c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0041010115000707$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25797317$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lu, Hao</creatorcontrib><creatorcontrib>Ma, Feng</creatorcontrib><creatorcontrib>Wang, Huan</creatorcontrib><creatorcontrib>Geng, Peng-shuai</creatorcontrib><creatorcontrib>Wang, Shan-shan</creatorcontrib><creatorcontrib>Wang, Jian-guo</creatorcontrib><creatorcontrib>Wu, Chen-chen</creatorcontrib><creatorcontrib>Zhao, Bao-yu</creatorcontrib><title>The effects of swainsonine on the activity and expression of α-mannosidase in BRL-3A cells</title><title>Toxicon (Oxford)</title><addtitle>Toxicon</addtitle><description>Swainsonine (SW) is the principal toxic ingredient of locoweeds, which can cause intensive vacuolar degeneration because of α-mannosidase inhibition after animal ingestion. While SW can lead to obvious liver damage in vivo, the mechanism of hepatotoxic damage caused by SW is not clear. Therefore, BRL-3A cells were treated for 24, 48, and 72 h with SW at various concentrations (0, 700, 900, 1100 μg/mL). The α-mannosidase (AMAN) activity was determined in BRL-3A cells using an enzyme substrate technique. The expression of mRNA and proteins of GM II (MAN2A1) and LAM (MAN2B1) in BRL-3A cells was detected by qPCR and Western-blot. The results showed that SW could significantly reduce the activity of AMAN in a time-dose effect relationship. Compared with the control group, the activity of AMAN significantly decreased only in the group treated with 1100 μg/mL SW for 24 h (P &lt; 0.01), but the activity decreased significantly (P &lt; 0.05 or P &lt; 0.01) in all experimental groups treated for 48 or 72 h. SW also significantly reduced the expression of MAN2A1 and MAN2B1 mRNA and proteins in a time-dose effect relationship (P &lt; 0.05 or P &lt; 0.01), while the inhibition of SW was stronger for MAN2B1 than for MAN2A1. These results suggest that SW can significantly reduce the activity and expression of α-mannosidase thus causing SW-induced hepatotoxic damage. •The effect of swainsonine on the activity and expression of α-mannosidase in hepatic cells was observed for the first time.•Swainsonine caused the damage of liver tissues through inhibiting the activity and expression of α-mannosidase in hepatic cells.</description><subject>alpha-Mannosidase - antagonists &amp; inhibitors</subject><subject>alpha-Mannosidase - genetics</subject><subject>alpha-Mannosidase - metabolism</subject><subject>Animals</subject><subject>Biocompatibility</subject><subject>Biomedical materials</subject><subject>BRL-3A cells</subject><subject>Cell Line</subject><subject>Cell Survival - drug effects</subject><subject>China</subject><subject>Damage</subject><subject>Enzyme Repression - drug effects</subject><subject>Gene expression</subject><subject>Golgi Apparatus - drug effects</subject><subject>Golgi Apparatus - enzymology</subject><subject>Hepatocytes - drug effects</subject><subject>Hepatocytes - enzymology</subject><subject>Hepatocytes - metabolism</subject><subject>In vivo testing</subject><subject>In vivo tests</subject><subject>Inhibition</subject><subject>Isoenzymes - antagonists &amp; inhibitors</subject><subject>Isoenzymes - genetics</subject><subject>Isoenzymes - metabolism</subject><subject>Kinetics</subject><subject>Locoweed</subject><subject>Lysosomes - drug effects</subject><subject>Lysosomes - enzymology</subject><subject>MAN2A1</subject><subject>MAN2B1</subject><subject>Oxytropis - chemistry</subject><subject>Proteins</subject><subject>Rats</subject><subject>RNA, Messenger - metabolism</subject><subject>Swainsonine</subject><subject>Swainsonine - toxicity</subject><subject>Toxins, Biological - toxicity</subject><issn>0041-0101</issn><issn>1879-3150</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkcFOGzEQhq2qqITAI7TysZddxuv12j5VFLWAFKkSghMHy-sdq44SO11vKDwWL9JnqqOkvcJpDvPN_P_MT8hHBjUD1p0v6yk9BZdi3QATNfAaQL0jM6akrjgT8J7MAFpWQcGPyUnOSwDgSncfyHEjpJacyRl5uPuJFL1HN2WaPM2_bYg5xRCRpkin0rVuCo9heqY2DhSfNiPmHEqv0H9eqrWNMeUw2Iw0RPr1dlHxC-pwtcqn5MjbVcazQ52T--_f7i6vq8WPq5vLi0XlWs6mSnGp2SBBDazV4FVfDuHCS9sKB8L1ijsPoL11tncDNl3XcpCya7ht-144Pief93s3Y_q1xTyZdcg7BzZi2mbDpATeKi3aN6C8UUxrBQUVe9SNKecRvdmMYW3HZ8PA7CIwS3OIwOwiMMDNzvmcfDpIbPs1Dv-n_v28AF_2AJafPAYcTXYBo8MhjCUGM6TwisRfVZ2aDA</recordid><startdate>20150601</startdate><enddate>20150601</enddate><creator>Lu, Hao</creator><creator>Ma, Feng</creator><creator>Wang, Huan</creator><creator>Geng, Peng-shuai</creator><creator>Wang, Shan-shan</creator><creator>Wang, Jian-guo</creator><creator>Wu, Chen-chen</creator><creator>Zhao, Bao-yu</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7U7</scope><scope>C1K</scope><scope>8FD</scope><scope>FR3</scope><scope>KR7</scope></search><sort><creationdate>20150601</creationdate><title>The effects of swainsonine on the activity and expression of α-mannosidase in BRL-3A cells</title><author>Lu, Hao ; Ma, Feng ; Wang, Huan ; Geng, Peng-shuai ; Wang, Shan-shan ; Wang, Jian-guo ; Wu, Chen-chen ; Zhao, Bao-yu</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c431t-83791d708d1490f8b00835f7a45c05cb83cf009facabcde26643077623a4bb5c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>alpha-Mannosidase - antagonists &amp; inhibitors</topic><topic>alpha-Mannosidase - genetics</topic><topic>alpha-Mannosidase - metabolism</topic><topic>Animals</topic><topic>Biocompatibility</topic><topic>Biomedical materials</topic><topic>BRL-3A cells</topic><topic>Cell Line</topic><topic>Cell Survival - drug effects</topic><topic>China</topic><topic>Damage</topic><topic>Enzyme Repression - drug effects</topic><topic>Gene expression</topic><topic>Golgi Apparatus - drug effects</topic><topic>Golgi Apparatus - enzymology</topic><topic>Hepatocytes - drug effects</topic><topic>Hepatocytes - enzymology</topic><topic>Hepatocytes - metabolism</topic><topic>In vivo testing</topic><topic>In vivo tests</topic><topic>Inhibition</topic><topic>Isoenzymes - antagonists &amp; inhibitors</topic><topic>Isoenzymes - genetics</topic><topic>Isoenzymes - metabolism</topic><topic>Kinetics</topic><topic>Locoweed</topic><topic>Lysosomes - drug effects</topic><topic>Lysosomes - enzymology</topic><topic>MAN2A1</topic><topic>MAN2B1</topic><topic>Oxytropis - chemistry</topic><topic>Proteins</topic><topic>Rats</topic><topic>RNA, Messenger - metabolism</topic><topic>Swainsonine</topic><topic>Swainsonine - toxicity</topic><topic>Toxins, Biological - toxicity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lu, Hao</creatorcontrib><creatorcontrib>Ma, Feng</creatorcontrib><creatorcontrib>Wang, Huan</creatorcontrib><creatorcontrib>Geng, Peng-shuai</creatorcontrib><creatorcontrib>Wang, Shan-shan</creatorcontrib><creatorcontrib>Wang, Jian-guo</creatorcontrib><creatorcontrib>Wu, Chen-chen</creatorcontrib><creatorcontrib>Zhao, Bao-yu</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Civil Engineering Abstracts</collection><jtitle>Toxicon (Oxford)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lu, Hao</au><au>Ma, Feng</au><au>Wang, Huan</au><au>Geng, Peng-shuai</au><au>Wang, Shan-shan</au><au>Wang, Jian-guo</au><au>Wu, Chen-chen</au><au>Zhao, Bao-yu</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The effects of swainsonine on the activity and expression of α-mannosidase in BRL-3A cells</atitle><jtitle>Toxicon (Oxford)</jtitle><addtitle>Toxicon</addtitle><date>2015-06-01</date><risdate>2015</risdate><volume>99</volume><spage>44</spage><epage>50</epage><pages>44-50</pages><issn>0041-0101</issn><eissn>1879-3150</eissn><abstract>Swainsonine (SW) is the principal toxic ingredient of locoweeds, which can cause intensive vacuolar degeneration because of α-mannosidase inhibition after animal ingestion. While SW can lead to obvious liver damage in vivo, the mechanism of hepatotoxic damage caused by SW is not clear. Therefore, BRL-3A cells were treated for 24, 48, and 72 h with SW at various concentrations (0, 700, 900, 1100 μg/mL). The α-mannosidase (AMAN) activity was determined in BRL-3A cells using an enzyme substrate technique. The expression of mRNA and proteins of GM II (MAN2A1) and LAM (MAN2B1) in BRL-3A cells was detected by qPCR and Western-blot. The results showed that SW could significantly reduce the activity of AMAN in a time-dose effect relationship. Compared with the control group, the activity of AMAN significantly decreased only in the group treated with 1100 μg/mL SW for 24 h (P &lt; 0.01), but the activity decreased significantly (P &lt; 0.05 or P &lt; 0.01) in all experimental groups treated for 48 or 72 h. SW also significantly reduced the expression of MAN2A1 and MAN2B1 mRNA and proteins in a time-dose effect relationship (P &lt; 0.05 or P &lt; 0.01), while the inhibition of SW was stronger for MAN2B1 than for MAN2A1. These results suggest that SW can significantly reduce the activity and expression of α-mannosidase thus causing SW-induced hepatotoxic damage. •The effect of swainsonine on the activity and expression of α-mannosidase in hepatic cells was observed for the first time.•Swainsonine caused the damage of liver tissues through inhibiting the activity and expression of α-mannosidase in hepatic cells.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>25797317</pmid><doi>10.1016/j.toxicon.2015.03.008</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0041-0101
ispartof Toxicon (Oxford), 2015-06, Vol.99, p.44-50
issn 0041-0101
1879-3150
language eng
recordid cdi_proquest_miscellaneous_1770348954
source MEDLINE; Elsevier ScienceDirect Journals
subjects alpha-Mannosidase - antagonists & inhibitors
alpha-Mannosidase - genetics
alpha-Mannosidase - metabolism
Animals
Biocompatibility
Biomedical materials
BRL-3A cells
Cell Line
Cell Survival - drug effects
China
Damage
Enzyme Repression - drug effects
Gene expression
Golgi Apparatus - drug effects
Golgi Apparatus - enzymology
Hepatocytes - drug effects
Hepatocytes - enzymology
Hepatocytes - metabolism
In vivo testing
In vivo tests
Inhibition
Isoenzymes - antagonists & inhibitors
Isoenzymes - genetics
Isoenzymes - metabolism
Kinetics
Locoweed
Lysosomes - drug effects
Lysosomes - enzymology
MAN2A1
MAN2B1
Oxytropis - chemistry
Proteins
Rats
RNA, Messenger - metabolism
Swainsonine
Swainsonine - toxicity
Toxins, Biological - toxicity
title The effects of swainsonine on the activity and expression of α-mannosidase in BRL-3A cells
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T22%3A59%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20effects%20of%20swainsonine%20on%20the%20activity%20and%20expression%20of%20%CE%B1-mannosidase%20in%20BRL-3A%20cells&rft.jtitle=Toxicon%20(Oxford)&rft.au=Lu,%20Hao&rft.date=2015-06-01&rft.volume=99&rft.spage=44&rft.epage=50&rft.pages=44-50&rft.issn=0041-0101&rft.eissn=1879-3150&rft_id=info:doi/10.1016/j.toxicon.2015.03.008&rft_dat=%3Cproquest_cross%3E1732819980%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1732819980&rft_id=info:pmid/25797317&rft_els_id=S0041010115000707&rfr_iscdi=true